Literature DB >> 10702411

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

I Tesseur1, J Van Dorpe, K Spittaels, C Van den Haute, D Moechars, F Van Leuven.   

Abstract

Epidemiological studies have established that the epsilon 4 allele of the ApoE gene (ApoE4) constitutes an important risk factor for Alzheimer's disease and might influence the outcome of central nervous system injury. The mechanism by which ApoE4 contributes to the development of neurodegeneration remains unknown. To test one hypothesis or mode of action of ApoE, we generated transgenic mice that overexpressed human ApoE4 in different cell types in the brain, using four distinct gene promoter constructs. Many transgenic mice expressing ApoE4 in neurons developed motor problems accompanied by muscle wasting, loss of body weight, and premature death. Overexpression of human ApoE4 in neurons resulted in hyperphosphorylation of the microtubule-associated protein tau. In three independent transgenic lines from two different promoter constructs, increased phosphorylation of protein tau was correlated with ApoE4 expression levels. Hyperphosphorylation of protein tau increased with age. In the hippocampus, astrogliosis and ubiquitin-positive inclusions were demonstrated. These findings demonstrate that expression of ApoE in neurons results in hyperphosphorylation of protein tau and suggests a role for ApoE in neuronal cytoskeletal stability and metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702411      PMCID: PMC1876840          DOI: 10.1016/S0002-9440(10)64963-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  81 in total

1.  Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.

Authors:  G Einstein; V Patel; P Bautista; M Kenna; L Melone; R Fader; K Karson; S Mann; A M Saunders; C Hulette; D Mash; A D Roses; D E Schmechel
Journal:  J Neuropathol Exp Neurol       Date:  1998-12       Impact factor: 3.685

2.  The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.

Authors:  S M Laws; K Taddei; G Martins; A Paton; C Fisher; R Clarnette; J Hallmayer; W S Brooks; S E Gandy; R N Martins
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

3.  The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.

Authors:  A R Ahmed; S H MacGowan; D Culpan; R W Jones; G K Wilcock
Journal:  Neurosci Lett       Date:  1999-03-26       Impact factor: 3.046

4.  A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic.

Authors:  R B DeMattos; F E Thorngate; D L Williams
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

5.  Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE.

Authors:  C Soulié; V Mitchell; L Dupont-Wallois; M C Chartier-Harlin; J C Beauvillain; A Delacourte; M L Caillet-Boudin
Journal:  Neurosci Lett       Date:  1999-04-16       Impact factor: 3.046

6.  Specific regional transcription of apolipoprotein E in human brain neurons.

Authors:  P T Xu; J R Gilbert; H L Qiu; J Ervin; T R Rothrock-Christian; C Hulette; D E Schmechel
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females.

Authors:  J Raber; D Wong; M Buttini; M Orth; S Bellosta; R E Pitas; R W Mahley; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment.

Authors:  I Genis; A Fisher; D M Michaelson
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

9.  High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.

Authors:  E Ghebremedhin; C Schultz; E Braak; H Braak
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

10.  Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.

Authors:  J P Brion; G Tremp; J N Octave
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more
  71 in total

1.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

Authors:  J Van Dorpe; L Smeijers; I Dewachter; D Nuyens; K Spittaels; C Van Den Haute; M Mercken; D Moechars; I Laenen; C Kuiperi; K Bruynseels; I Tesseur; R Loos; H Vanderstichele; F Checler; R Sciot; F Van Leuven
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Authors:  John M Ringman; David Elashoff; Daniel H Geschwind; Brian T Welsh; Karen H Gylys; Cathy Lee; Jeffrey L Cummings; Greg M Cole
Journal:  Arch Neurol       Date:  2012-06

3.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity.

Authors:  Shengjun Chang; Tian ran Ma; R Dennis Miranda; Maureen E Balestra; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 5.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

6.  Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies.

Authors:  Steven W Barger; Kevin Mark DeWall; Ling Liu; Robert E Mrak; W Sue T Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

7.  Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice.

Authors:  Ke-Feng Tang; Li Cai; Jiang-Ning Zhou
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

8.  Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Craig Stockmeier; Xiaoming Ou; Ian Paul; Thomas Mosley; Karl Weisgraber; Jun Ming Wang
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

9.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

10.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

Authors:  Faith M Harris; Walter J Brecht; Qin Xu; Ina Tesseur; Lisa Kekonius; Tony Wyss-Coray; Jo Dee Fish; Eliezer Masliah; Paul C Hopkins; Kimberly Scearce-Levie; Karl H Weisgraber; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.